Current Status of Photodynamic Therapy for Bile Duct Cancer

키워드

참고문헌 (46)

1. Nakeeb A, "Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors", Ann Surg, 224, pp.463~473 (1996)
2. Bismuth H, "Resection or palliation: priority of surgery in the treatment of hilar cancer", World J Surg, 12, pp.39~47 (1988)
3. Rea DJ, "Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients", Arch Surg, 139, pp.514~523 (2004)
4. Jarnagin WR, "Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma", Ann Surg, 234, pp.507~517 (2001)
5. Zoepf T, "Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy", Am J Gastroenterol, 100, pp.2426~2430 (2005)
6. Ortner ME, "Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study", Gastroenterology, 125, pp.1355~1363 (2003)
7. Wong Kee Song LM, "Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model", Cancer, 82, pp.421~427 (1998)
8. Oertel M, "Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model", J Photochem Photobiol B, 71, pp.1~10 (2003)
9. de Groen PC, "Biliary tract cancers", N Engl J Med, 341, pp.1368~1378 (1999)
10. Gores GJ., "Cholangiocarcinoma: current concepts and insights", Hepatology, 37, pp.961~969 (2003)
11. Weinbren K, "Pathological aspects of cholangiocarcinoma", J Pathol, 139, pp.217~238 (1983)
12. Shimada H, "The infiltration of bile duct carcinoma along the bile duct wall", Int Surg, 73, pp.87~90 (1988)
13. Sakamoto E, "The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases", Ann Surg, 227, pp.405~411 (1998)
14. Sako K, "Carcinoma of the extrahepatic bile ducts: review of the literature and report of six cases", Surgery, 41, pp.416~437 (1957)
15. Gertsch P, "Multiple tumors of the biliary tract", Am J Surg, 159, pp.386~388 (1990)
16. Berr F, "Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma", J Hepatol, 32, pp.352~357 (2000)
17. Burke EC, "Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system", Ann Surg, 228, pp.385~394 (1998)
18. Polydorou AA, "Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion", Gut, 32, pp.685~689 (1991)
19. Ducreux M, "Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors", Dig Dis Sci, 37, pp.778~783 (1992)
20. Chang WH, "Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage", Gastrointest Endosc, 47, pp.354~362 (1998)
21. Davids PH, "Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction", Lancet, 340, pp.1488~1492 (1992)
22. Kaassis M, "Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study", Gastrointest Endosc, 57, pp.178~182 (2003)
23. Valle J, "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer", N Engl J Med, 362, pp.1273~1281 (2010)
24. Bowling TE, "A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma", Gut, 39, pp.852~855 (1996)
25. Momm F, "Stereotactic fractionated radiotherapy for Klatskin tumours", Radiother Oncol, 95, pp.99~102 (2010)
26. Molt P, "Intraluminal radiation therapy in the management of malignant biliary obstruction", Cancer, 57, pp.536~544 (1986)
27. 천영국, "진행성 간문부담관암 환자에서 내시경 담도배액술 단독 치료와 경피경간 담도배액술을 병행한 담도경하 광역동치료의 생존율의 비교 연구", 대한소화기학회지, 44(5), pp.280~287 (2004), 대한소화기학회
28. Wiedmann M, "Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study", Cancer, 97, pp.2783~2790 (2003)
29. Kiesslich T, "Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines", Photochem Photobiol Sci, 6, pp.619~627 (2007)
30. McCaughan JS Jr, "Photodynamic therapy to treat tumors of the extrahepatic biliary ducts", A case report. Arch Surg, 126, pp.111~113 (1991)
31. Ortner MA, "Photodynamic therapy of nonresectable cholangiocarcinoma", Gastroenterology, 114, pp.536~542 (1998)
32. Tomizawa Y, , Dig Dis Sci, 57, pp.274~283 (2012)
33. Quyn AJ, "Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma", HPB (Oxford), 11, pp.570~577 (2009)
34. Lee TY, "Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma", World J Gastroenterol, 18, pp.5589~5594 (2012)
35. Nanashima A, "Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study", J Gastroenterol, 39, pp.1095~1101 (2004)
36. Berr F, "Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival", Hepatology, 31, pp.291~298 (2000)
37. Shim CS, "Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment", Endoscopy, 37, pp.425~433 (2005)
38. Utsumi K, "Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production", J Immunol, 145, pp.397~403 (1990)
39. Cheon YK, "Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy", Am J Gastroenterol, 102, pp.2164~2170 (2007)
40. Goydos JS, "Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker", Ann Surg, 227, pp.398~404 (1998)
41. Prasad GA, "Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma", Clin Gastroenterol Hepatol, 5, pp.743~748 (2007)
42. Cheon YK, "Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma", HPB (Oxford), 14, pp.185~193 (2012)
43. Dumoulin FL, "Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma", Gastrointest Endosc, 57, pp.860~867 (2003)
44. Kahaleh M, "Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy", Clin Gastroenterol Hepatol, 6, pp.290~297 (2008)
45. Witzigmann H, "Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1", r2 resection, 2006, pp.244, 230~239
46. Wiedmann M, "Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study", Gastrointest Endosc, 60, pp.68~75 (2004)

관련 논문AI추천